This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Disease Modelling 2023
May 03-04, 2023
2-Day Digital Conference8:00AM EDT // 1:00PM BST // 2:00PM CEST
Menu

Clare Jones
Chief Scientific Officer at Talisman Therapeutics, UK
Speaker

Agenda Sessions

  • Modelling Alzheimer’s Disease using Induced-Pluripotent Stem Cells (IPSCs)

    , 08:05
    View Session

At this event

Prev
Next
Joshua Mann, MPH
Director of Health
VHL Alliance, USA

See Clare at Disease Modelling 2023